Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
17 Mar 2011
Xyrem® not recommended for fibromyalgia syndrome in the EU
Read More
8 Mar 2011
UCB completes placement of EUR 300 million perpetual subordinated bonds
Read More
7 Mar 2011
UCB launches offering of perpetual subordinated bonds
Read More
7 Mar 2011
Journalists recognised for excellence in reporting on epilepsy
Read More
2 Mar 2011
UCB: Jaarlijks financieel verslag 2010 - een jaar van sterke resultaten
Read More
2 Mar 2011
UCB: résultats financiers 2010 - une année 2010 riche en réalisations
Read More
2 Mar 2011
UCB Full-year Report 2010: a year of strong delivery
Read More
1 Mar 2011
UCB and its Design Partners OXO Win Coveted Design Award for Cimzia® Syringe and Packaging
Read More
28 Feb 2011
UCB Establishes Innovative Collaboration with Harvard University
Read More
14 Feb 2011
UCB reinforces commitment to epilepsy community on European Epilepsy Day
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
75
Page
76
Page
77
Page
78
Current page
79
Page
80
Page
81
Page
82
Page
83
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss